Literature DB >> 28133431

Assessment and Treatment of Bipolar Spectrum Disorders in Emerging Adulthood: Applying the Behavioral Approach System Hypersensitivity Model.

Elissa J Hamlat1, Jared K O' Garro-Moore1, Robin Nusslock1, Lauren B Alloy1.   

Abstract

Bipolar disorder is associated with a host of negative physical and interpersonal outcomes including suicide. Emerging adulthood is an age of risk for the onset of bipolar spectrum disorders (BSD) and there has been increased effort to focus on early identification and subsequent intervention for BSDs during this developmental period. Recent research on the behavioral approach system (BAS) hypersensitivity model of bipolar disorder may have implications for the assessment and treatment of BSD in emerging adulthood. We summarize relevant findings on the BAS hypersensitivity model that support the use of reward sensitivity in the early identification of BSDs and suggest evidence-based strategies for clinical work with emerging adults with bipolar spectrum disorders.

Entities:  

Year:  2016        PMID: 28133431      PMCID: PMC5270687          DOI: 10.1016/j.cbpra.2016.05.001

Source DB:  PubMed          Journal:  Cogn Behav Pract        ISSN: 1077-7229


  92 in total

1.  Emerging adulthood. A theory of development from the late teens through the twenties.

Authors:  J J Arnett
Journal:  Am Psychol       Date:  2000-05

Review 2.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

3.  Increased rates of events that activate or deactivate the behavioral approach system, but not events related to goal attainment, in bipolar spectrum disorders.

Authors:  Snezana Urosević; Lyn Y Abramson; Lauren B Alloy; Robin Nusslock; Eddie Harmon-Jones; Rachel Bender; Michael E Hogan
Journal:  J Abnorm Psychol       Date:  2010-08

Review 4.  Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence.

Authors:  Snezana Urosević; Lyn Y Abramson; Eddie Harmon-Jones; Lauren B Alloy
Journal:  Clin Psychol Rev       Date:  2008-05-09

5.  A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year.

Authors:  Dominic H Lam; Edward R Watkins; Peter Hayward; Jenifer Bright; Kim Wright; Natalie Kerr; Gina Parr-Davis; Pak Sham
Journal:  Arch Gen Psychiatry       Date:  2003-02

6.  Behavioral Approach System and Behavioral Inhibition System sensitivities and bipolar spectrum disorders: prospective prediction of bipolar mood episodes.

Authors:  Lauren B Alloy; Lyn Y Abramson; Patricia D Walshaw; Alex Cogswell; Louisa D Grandin; Megan E Hughes; Brian M Iacoviello; Wayne G Whitehouse; Snezana Urosevic; Robin Nusslock; Michael E Hogan
Journal:  Bipolar Disord       Date:  2008-03       Impact factor: 6.744

7.  GAMIAN-Europe/BEAM survey I--global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders.

Authors:  Paolo Lucio Morselli; Rodney Elgie
Journal:  Bipolar Disord       Date:  2003-08       Impact factor: 6.744

8.  Effect of bipolar disorder on left frontal cortical responses to goals differing in valence and task difficulty.

Authors:  Eddie Harmon-Jones; Lyn Y Abramson; Robin Nusslock; Jonathan D Sigelman; Snezana Urosevic; Lee D Turonie; Lauren B Alloy; Meghan Fearn
Journal:  Biol Psychiatry       Date:  2007-10-24       Impact factor: 13.382

9.  How does a Developmental Perspective inform us about the early Natural History of Bipolar Disorder?

Authors:  Anne Duffy; Gabrielle A Carlson
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-02

10.  Psychosocial Interventions for Bipolar Disorder: Perspective from the Behavioral Approach System (BAS) Dysregulation Theory.

Authors:  Robin Nusslock; Lyn Y Abramson; Eddie Harmon-Jones; Lauren B Alloy; James A Coan
Journal:  Clin Psychol (New York)       Date:  2009-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.